Centro de Dermatologia de Monterrey

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Study of Zasocitinib in Adults With Nonsegmental Vitiligo	Nonsegmental Vitiligo	Recruiting	Phase 2	2026-09-30		NCT07108283
A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo	Skin and Connective Tissue Diseases, hypopigmentation of the skin, skin disorder, skin pigmentation disorder, vitiligo	Active, not recruiting	Phase 3	2026-09-28		NCT06163326

Clinical trials